Published in Clin Exp Immunol on April 01, 1972
Mitochondrial antibodies (AMA). Gut (1974) 1.60
Primary biliary cirrhosis in brothers. Postgrad Med J (1975) 1.44
Chronic hepatitis. Gut (1974) 1.30
The epidemiology of primary biliary cirrhosis: a survey of mortality in England and Wales. Gut (1974) 1.09
Primary biliary cirrhosis in mother and daughter. Br Med J (1977) 1.04
Are increased individual susceptibility and environmental factors both necessary for the development of primary biliary cirrhosis? Br Med J (1979) 1.03
ABO blood groups, Rhesus negativity, and primary biliary cirrhosis. Gut (1974) 0.93
HLA-DR antigens in primary biliary cirrhosis: lack of association. Gut (1985) 0.92
The immunology of liver disorders. Proc R Soc Med (1974) 0.86
Human antibodies to mast cells. Clin Exp Immunol (1973) 0.78
Primary biliary cirrhosis-specific autoantibodies in first degree relatives of Greek primary biliary cirrhosis patients. World J Gastroenterol (2012) 0.77
Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry (1965) 96.68
SEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS. Lancet (1965) 6.41
Serological and histological diagnosis of primary biliary cirrhosis. J Clin Pathol (1966) 2.78
Immunoglobulins in chronic liver disease. Gut (1968) 2.39
The occurrence of rheumatoid factor and other abnormalities in families of patients with agammaglobulinemia. Arthritis Rheum (1962) 2.31
Mitochondrial antibodies and subclinical liver disease. Q J Med (1970) 2.28
Evidence for genetic predisposition to formation of thyroid autoantibodies. Lancet (1960) 2.14
A FAMILY STUDY OF PERNICIOUS ANEMIA BY AN IMMUNOLOGIC METHOD. J Lab Clin Med (1964) 2.03
Liver disease in Sjögren's syndrome and rheumatoid arthritis. Lancet (1970) 2.00
FAMILIAL CIRRHOSIS: A CLINICAL AND PATHOLOGICAL STUDY. Ann Intern Med (1964) 1.53
Antibodies to cytoplasmic antigens in primary biliary cirrhosis and chronic active hepatitis. J Lab Clin Med (1967) 1.46
Autoimmunity in pernicious anemia and thyroiditis: a family study. Ann N Y Acad Sci (1965) 1.45
Immunological and histological studies in primary biliary cirrhosis. J Clin Pathol (1970) 1.29
Primary acquired agammaglobulinemia, with a family history of collagen disease and hematologic disorders. N Engl J Med (1962) 1.21
Serum proteins in liver disease. Proc R Soc Med (1967) 1.15
HEREDITARY HYPERGAMMAGLOBULINEMIA AND LUPOID HEPATITIS. Acta Med Scand (1965) 1.14
Family studies in systemic lupus erythematosus. Clin Exp Immunol (1967) 1.10
Familial cirrhosis with autoimmune features and raised immunoglobulin levels. Gastroenterology (1970) 1.04
[Immunologic phenomena in liver diseases: significance of mitochondrial antibodies]. Klin Wochenschr (1969) 1.04
A genetic approach to the pathogenesis of hepatic cirrhosis. A clinical and serological study. Acta Med Scand (1966) 1.02
Liver cirrhosis in patients with a lupus erythematosus-like syndrome. Acta Med Scand (1961) 0.96
Serological diagnosis of primary biliary cirrhosis: a potential clue to pathogenesis. Trans Assoc Am Physicians (1967) 0.90
A reassessment of studies on the aggregation of thyroid autoimmunity in families of thyroiditis patients. Clin Exp Immunol (1967) 0.89
Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Clin Exp Immunol (1966) 8.26
The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med (1973) 6.65
Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet (1974) 5.59
Cellular immunity and hepatitis-associated, Australia antigen liver disease. Lancet (1972) 5.17
Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut (1980) 4.09
Galectins: a family of animal beta-galactoside-binding lectins. Cell (1994) 3.99
Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet (1983) 3.85
A unified concept of autoimmune hepatitis. Lancet (1969) 3.74
Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens. Nature (1985) 3.68
Intrinsic-factor antibodies in absence of pernicious anaemia. 3-7 year follow-up. Lancet (1970) 3.36
Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med (1971) 3.23
Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy. Lancet (1968) 3.10
Types of 'reticulin' antibodies detected in human sera by immunofluorescence. J Clin Pathol (1973) 2.98
The epidemiology of testicular cancer in young adults. Am J Epidemiol (1980) 2.90
The aetiology, presentation and natural history of extra-hepatic portal venous obstruction. Q J Med (1979) 2.84
Spread of acute type-B hepatitis in London. Lancet (1973) 2.82
Measurement of liver-iron concentration in needle-biopsy specimens. Lancet (1971) 2.65
Arterial changes in the lungs in cirrhosis of the liver--lung spider nevi. N Engl J Med (1966) 2.65
Unexplained hepatitis following halothane. Br Med J (1976) 2.62
Relationship of hepatitis-associated antigen (H.A.A.) to acute and chronic liver injury. Lancet (1971) 2.61
Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology (1994) 2.60
Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum. Lancet (1970) 2.60
Microsomal antibodies in active chronic hepatitis and other disorders. Clin Exp Immunol (1973) 2.59
Serum ferritin in patients with iron overload and with acute and chronic liver diseases. Gastroenterology (1975) 2.58
Idiotypic determinants of immunoglobulin M detected on the surface of human lymphocytes by cytotoxicity assays. J Exp Med (1972) 2.47
Partial nodular transformation of the liver with portal hypertension. Am J Med (1966) 2.45
Retracted Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity. Nature (1994) 2.43
Cell-mediated immunity in patients positive for hepatitis-associated antigen. Br Med J (1972) 2.39
Immunoglobulins in chronic liver disease. Gut (1968) 2.39
Aberrant expression of HLA-DR antigens on bileduct epithelium in primary biliary cirrhosis: relevance to pathogenesis. Lancet (1984) 2.38
Stage-specific embryonic antigen involves alpha 1 goes to 3 fucosylated type 2 blood group chains. Nature (1981) 2.35
Niemann-Pick disease type C: diagnosis and outcome in children, with particular reference to liver disease. J Pediatr (1993) 2.32
Mitochondrial antibodies and subclinical liver disease. Q J Med (1970) 2.28
A randomized trial of percutaneous transhepatic cholangiography with the Chiba needle versus endoscopic retrograde cholangiography for bile duct visualization in jaundice. Gastroenterology (1976) 2.25
Diagnosis of Gilbert's syndrome: role of reduced caloric intake test. Br Med J (1973) 2.21
Impaired delayed hypersensitivity in primary biliary cirrhosis. Lancet (1969) 2.19
Risk factors in community-acquired chronic hepatitis C virus infection: a case-control study in Italy. J Hepatol (1996) 2.19
Is primary biliary cirrhosis an immune complex disease? Lancet (1977) 2.15
Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis. Lancet (1992) 2.13
Idiotypic specificity of surface immunoglobulin and the maturation of leukemic bone-marrow-derived lymphocytes. Proc Natl Acad Sci U S A (1974) 2.13
The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis. Gastroenterology (1982) 2.11
Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med (1983) 2.10
Mitochondrial antibodies in primary biliary cirrhosis. I. Localization of the antigen to mitochondrial membranes. J Exp Med (1967) 2.09
Complications of diuretic therapy in hepatic cirrhosis. Lancet (1966) 2.09
Classification of smooth muscle autoantibodies detected by immunofluorescence. J Clin Pathol (1976) 2.08
Presence of the organ-specific 'microsomal' autoantigen on the surface of human thyroid cells in culture: its involvement in complement-mediated cytotoxicity. Clin Exp Immunol (1981) 2.04
Hereditary spherocytosis with secondary haemochromatosis. Lancet (1968) 2.00
A collagen disorder of the nervous system presenting as multiple sclerosis. Brain (1972) 2.00
The occurrence of autoantibodies in infectious mononucleosis. Clin Exp Immunol (1974) 2.00
Complement-fixing islet-cell antibodies in type-I diabetes: possible monitors of active beta-cell damage. Lancet (1980) 2.00
New antibody in early syphilis. Lancet (1970) 1.97
Immune complexes in acute and chronic liver disease. Clin Exp Immunol (1978) 1.93
Autoantibodies to prolactin-secreting cells of human pituitary. Lancet (1975) 1.92
The pathology of hepatitis C. Hepatology (1992) 1.92
Histocompatibility antigens, autoantibodies, and immunoglobulins in alcoholic liver disease. Br Med J (1976) 1.91
Incidence and clinical significance of e antigen and antibody in acute and chronic liver disease. Lancet (1975) 1.90
Enhanced antibody responses in active chronic hepatitis: relation to HLA-B8 and HLA-B12 and porto-systemic shunting. Lancet (1976) 1.89
Sex-related differences among 100 patients with alcoholic liver disease. Br Med J (1977) 1.89
The antigenic determinants recognized by three monoclonal antibodies to keratan sulphate involve sulphated hepta- or larger oligosaccharides of the poly(N-acetyllactosamine) series. Eur J Biochem (1986) 1.88
Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial. Gastroenterology (1985) 1.86
Induction of remission in hepatocellular carcinoma with doxorubicin. Lancet (1978) 1.86
Hepatitis-associated antigen in chronic liver disease. Lancet (1969) 1.82
Carbohydrate structures of the human-immunodeficiency-virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese-hamster ovary cells. Biochem J (1988) 1.81
Association of primary sclerosing cholangitis with HLA-B8. Gut (1983) 1.79
Hemolytic anemia in Wilson's disease. N Engl J Med (1967) 1.78
Histological features after liver transplantation in alcoholic cirrhotics. J Hepatol (2001) 1.69
How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system. Cancer (2000) 1.68
Bone disease and calcium absorption in primary biliary cirrhosis with special reference to vitamin-D therapy. Lancet (1968) 1.67
Primary sclerosing cholangitis, the biliary tree, and ulcerative colitis. Gut (1967) 1.67
Short incubation non-A, non-B hepatitis transmitted by factor VIII concentrates in patients with congenital coagulation disorders. Gut (1981) 1.67
Mitochondrial antibodies in chronic liver diseases and connective tissue disorders: further characterization of the autoantigens. Clin Exp Immunol (1980) 1.66
Erythrocyte receptors for Mycoplasma pneumoniae are sialylated oligosaccharides of Ii antigen type. Nature (1984) 1.66
The Budd-Chiari syndrome: correlation between hepatic scintigraphy and the clinical, radiological, and pathological findings in nineteen cases of hepatic venous outflow obstruction. Gastroenterology (1975) 1.66
Presentation and course of asymptomatic primary biliary cirrhosis. Gastroenterology (1977) 1.65
Hepatic disorders associated with liver-kidney microsomal antibodies. Br Med J (1974) 1.64
Light chain sequences of human IgM cold agglutinins (variable-region subgroups amino-acid sequence-kappa light chain-N-terminal). Proc Natl Acad Sci U S A (1972) 1.64
Chronic atrophic gastritis and Helicobacter pylori infection in primary biliary cirrhosis: a cross-sectional study with matching. Ital J Gastroenterol Hepatol (1997) 1.63
Rat natural killer cell antigen, NKR-P1, related to C-type animal lectins is a carbohydrate-binding protein. J Biol Chem (1994) 1.62
Immunological studies in an epidemic of infective, short-incubation hepatitis. Lancet (1972) 1.62
Thymus-dependent lymphocyte function in patients with hepatitis-associated antigen. Lancet (1972) 1.60
Renal and intrarenal blood-flow in cirrhosis of the liver. Lancet (1971) 1.60
Mitochondrial antibodies (AMA). Gut (1974) 1.60
Natural history of hepatitis-associated antigen-positive chronic liver disease. Lancet (1972) 1.59
Characterization of a blood group I-active ganglioside. Structural requirements for I and i specificities. J Biol Chem (1979) 1.58
Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis. Gut (1986) 1.58
Arsenic and noncirrhotic portal hypertension. Gastroenterology (1974) 1.57
Oxidative DNA damage accumulation in gastric carcinogenesis. Gut (1998) 1.57
Vitamin A treatment for night blindness in primary biliary cirrhosis. Br Med J (Clin Res Ed) (1984) 1.57
High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis. N Engl J Med (1974) 1.56
Hepatobiliary fibropolycystic diseases. A clinical and histological review of 51 patients. J Hepatol (1986) 1.55
Evidence for a primary autoimmune type of diabetes mellitus. Br Med J (1978) 1.55
Percutaneous liver biopsy in patients with large bile duct obstruction. Gastroenterology (1975) 1.53
Chronic pancreatitis: a cause of cholestasis. Gut (1977) 1.51
Characterization of the microsomal antigen related to a subclass of active chronic hepatitis. Immunology (1974) 1.50